Literature DB >> 1909407

Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model.

H Matsuno1, T Uematsu, S Nagashima, M Nakashima.   

Abstract

We report a new and reproducible model of thrombosis in the rat femoral artery. The thrombosis is initiated by endothelial injury subsequent to photochemical reaction between systemically injected rose bengal (10 mg/kg, i.v.) and transillumination of filtered xenon lamp (wave length: 540 nm) from the outside of the vessel. The blood flow of the femoral artery, which was monitored by a pulsed doppler flow meter, was fully stopped in 348.68 +/- 36.18 sec (n = 12) after i.v. injection of rose bengal under irradiation with green light. The formation of massive thrombosis was readily evident by visual inspection. The processes of primary endothelial injury and the subsequent formation of thrombosis during this manipulation were observed by light microscopy and analysed by the scanning and transmission electron microscopy. Pretreatment with heparin (30, 100 or 300 units/kg, i.v.) 10 min before rose bengal injection dose-dependently prolonged the time required to interrupt the blood flow. The thrombolytic activity of a tissue-type plasminogen activator (tPA) was also investigated. After the establishment of stable thrombotic occlusion of the femoral artery, infusion of tPA was started from the contralateral femoral vein for 30 min at the rate of 30 or 100 micrograms/kg/min. The occluded artery was reperfused in 2 out of 10 rats and in 9 out of 12 at the lower and higher rates of tPA infusion, respectively. That heparin could prevent the arterial occlusion and that tPA could reperfuse the occluded artery are observations consistent with the histopathological ones that the primary lesion of endothelium injured photochemically activates the platelet aggregation to form platelet-rich thrombus with extensions of erythrocyte-rich lesions. This model is expected to be a useful tool for evaluating the antithrombotic and thrombolytic agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909407     DOI: 10.1016/0160-5402(91)90030-9

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  12 in total

1.  Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.

Authors:  H Matsuno; T Uematsu; K Umemura; Y Takiguchi; K Wada; M Nakashima
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.

Authors:  Ying Yu; Yan Cheng; Jinjin Fan; Xin-Sheng Chen; Andres Klein-Szanto; Garret A Fitzgerald; Colin D Funk
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

3.  Nitrophorin 2, a factor IX(a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis.

Authors:  Daniella M Mizurini; Ivo M B Francischetti; John F Andersen; Robson Q Monteiro
Journal:  Thromb Haemost       Date:  2010-09-13       Impact factor: 5.249

4.  Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  Lasers Med Sci       Date:  2007-03       Impact factor: 3.161

5.  Thrombolytic effect of a plasminogen-plasminogen activator chimera in a photochemically induced thrombosis (PIT) model.

Authors:  H Matsuno; T Uematsu; M Nakashima
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.

Authors:  Li He; Tusar K Giri; Cristina P Vicente; Douglas M Tollefsen
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

7.  An animal model for hearing disturbance due to inner ear ischemia: photochemically induced thrombotic occlusion of the rat anterior inferior cerebellar artery.

Authors:  Y Asai; K Umemura; Y Kohno; T Uematsu; M Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  A comparative study of the antithrombotic effect of aurintricarboxylic acid on arterial thrombosis in rats and guinea pigs.

Authors:  Y Takiguchi; M Shimazawa; M Nakashima
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation.

Authors:  M Fukuchi; T Uematsu; S Araki; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

10.  Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model.

Authors:  Y Takiguchi; F Asai; K Wada; H Hayashi; M Nakashima
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.